Clover Health [CLOV] vs CVS Health [CVS] Detailed Stock Comparison

Clover Health

CVS Health
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Clover Health wins in 4 metrics, CVS Health wins in 14 metrics, with 0 ties. CVS Health appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Clover Health | CVS Health | Better |
---|---|---|---|
P/E Ratio (TTM) | -32.37 | 21.58 | Clover Health |
Price-to-Book Ratio | 3.84 | 1.27 | CVS Health |
Debt-to-Equity Ratio | 0.00 | 106.67 | Clover Health |
PEG Ratio | 0.11 | -0.51 | CVS Health |
EV/EBITDA | -27.43 | 11.95 | Clover Health |
Profit Margin (TTM) | -2.68% | 1.18% | CVS Health |
Operating Margin (TTM) | -2.21% | 2.80% | CVS Health |
EBITDA Margin (TTM) | N/A | 2.80% | N/A |
Return on Equity | -12.59% | 5.88% | CVS Health |
Return on Assets (TTM) | -4.26% | 2.29% | CVS Health |
Free Cash Flow (TTM) | $33.29M | $6.33B | CVS Health |
Dividend Yield | N/A | 3.01% | N/A |
1-Year Return | -35.89% | 19.97% | CVS Health |
Price-to-Sales Ratio (TTM) | 0.83 | 0.26 | CVS Health |
Enterprise Value | $1.13B | $167.01B | CVS Health |
EV/Revenue Ratio | 0.70 | 0.44 | CVS Health |
Gross Profit Margin (TTM) | 20.86% | 13.74% | Clover Health |
Revenue per Share (TTM) | $3 | $305 | CVS Health |
Earnings per Share (Diluted) | $-0.08 | $3.59 | CVS Health |
Beta (Stock Volatility) | 2.11 | 0.61 | CVS Health |
Clover Health vs CVS Health Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Clover Health | 1.16% | -19.06% | -2.63% | 1.17% | -26.21% | -17.25% |
CVS Health | -0.84% | 2.27% | 5.69% | 14.92% | 14.78% | 75.24% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Clover Health | -35.89% | 64.97% | -75.50% | -74.61% | -74.61% | -74.61% |
CVS Health | 19.97% | -12.19% | 30.45% | -24.03% | 147.97% | 202.93% |
News Based Sentiment: Clover Health vs CVS Health
Clover Health
News based Sentiment: NEGATIVE
October was a turbulent month for Clover Health, dominated by stock declines triggered by regulatory concerns surrounding ACA tax credits and a notable insider sale by the CEO. While institutional investors increased their holdings, the negative sentiment stemming from policy uncertainty and insider activity overshadows these positive developments, making it a significant month for investors to assess the company's risk profile.
CVS Health
News based Sentiment: MIXED
September presented a mixed bag for CVS Health, with strong earnings and strategic investments offset by significant legal challenges like the Omnicare bankruptcy and ongoing lawsuits. While the market reacted positively to some news, the legal liabilities and potential financial impacts create uncertainty, making it a moderately important month for investors.
Performance & Financial Health Analysis: Clover Health vs CVS Health
Metric | CLOV | CVS |
---|---|---|
Market Information | ||
Market Cap | $1.62B | $98.78B |
Market Cap Category | Small cap | Large cap |
10 Day Avg. Volume | 11,497,670 | 6,881,243 |
90 Day Avg. Volume | 7,062,627 | 7,195,044 |
Last Close | $2.62 | $76.84 |
52 Week Range | $2.12 - $4.87 | $43.56 - $79.20 |
% from 52W High | -46.20% | -2.98% |
All-Time High | $28.85 (Jun 07, 2021) | $113.65 (Jul 27, 2015) |
% from All-Time High | -90.92% | -32.39% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.34% | 0.08% |
Quarterly Earnings Growth | 0.34% | -0.42% |
Financial Health | ||
Profit Margin (TTM) | -0.03% | 0.01% |
Operating Margin (TTM) | -0.02% | 0.03% |
Return on Equity (TTM) | -0.13% | 0.06% |
Debt to Equity (MRQ) | 0.00 | 106.67 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | $0.67 | $61.07 |
Cash per Share (MRQ) | $0.39 | $11.18 |
Operating Cash Flow (TTM) | $-46,732,000 | $7.57B |
Levered Free Cash Flow (TTM) | $83.15M | $5.83B |
Dividends | ||
Last 12-Month Dividend Yield | N/A | 3.01% |
Last 12-Month Dividend | N/A | $2.01 |
Valuation & Enterprise Metrics Analysis: Clover Health vs CVS Health
Metric | CLOV | CVS |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | -32.37 | 21.58 |
Forward P/E | -18.50 | 11.96 |
PEG Ratio | 0.11 | -0.51 |
Price to Sales (TTM) | 0.83 | 0.26 |
Price to Book (MRQ) | 3.84 | 1.27 |
Market Capitalization | ||
Market Capitalization | $1.62B | $98.78B |
Enterprise Value | $1.13B | $167.01B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 0.70 | 0.44 |
Enterprise to EBITDA | -27.43 | 11.95 |
Risk & Other Metrics | ||
Beta | 2.11 | 0.61 |
Book Value per Share (MRQ) | $0.67 | $61.07 |
Financial Statements Comparison: Clover Health vs CVS Health
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | CLOV | CVS |
---|---|---|
Revenue/Sales | $462.33M | $94.59B |
Cost of Goods Sold | $353.44M | $80.19B |
Gross Profit | $108.89M | $14.40B |
Research & Development | N/A | N/A |
Operating Income (EBIT) | $-1.27M | $3.37B |
EBITDA | $-808,000 | $4.56B |
Pre-Tax Income | $-1.27M | $2.62B |
Income Tax | N/A | $835.00M |
Net Income (Profit) | $-1.27M | $1.78B |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | CLOV | CVS |
---|---|---|
Cash & Equivalents | $155.44M | $10.08B |
Total Current Assets | $331.41M | $73.19B |
Total Current Liabilities | $215.65M | $88.96B |
Long-Term Debt | N/A | $73.63B |
Total Shareholders Equity | $336.08M | $77.11B |
Retained Earnings | $-2.20B | $63.77B |
Property, Plant & Equipment | $5.03M | $28.56B |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | CLOV | CVS |
---|---|---|
Operating Cash Flow | $-24.27M | $3.96B |
Capital Expenditures | $-185,000 | $-743.00M |
Free Cash Flow | $-16.48M | $3.81B |
Debt Repayment | N/A | $-743.00M |
Common Stock Repurchase | $-31.96M | $0 |
Short Interest & Institutional Ownership Analysis
Metric | CLOV | CVS |
---|---|---|
Shares Short | 49.28M | 23.62M |
Short Ratio | 9.76 | 3.26 |
Short % of Float | 0.12% | 0.02% |
Average Daily Volume (10 Day) | 11,497,670 | 6,881,243 |
Average Daily Volume (90 Day) | 7,062,627 | 7,195,044 |
Shares Outstanding | 503.53M | 1.26B |
Float Shares | 400.54M | 1.27B |
% Held by Insiders | 0.04% | 0.01% |
% Held by Institutions | 0.35% | 0.88% |
Dividend Analysis & Yield Comparison: Clover Health vs CVS Health
Metric | CLOV | CVS |
---|---|---|
Last 12-Month Dividend | N/A | $2.01 |
Last 12-Month Dividend Yield | N/A | 3.01% |
3-Year Avg Annual Dividend | N/A | $2.28 |
3-Year Avg Dividend Yield | N/A | 0.87% |
3-Year Total Dividends | N/A | $6.85 |
Ex-Dividend Date | N/A | Apr 22, 2025 |